{"Q": 1, "answer": "no", "rationale": "No intensifier or comparative adjective directly modifies a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_1716", "batch_size": 200, "batch_pos": 81, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment uses neutral language.", "method": "llm_batch", "batch_id": "batch_2_6220", "batch_size": 200, "batch_pos": 42, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "Factual reporting of action/plan, no moderate verb + scale of impact.", "method": "llm_batch", "batch_id": "batch_3_9108", "batch_size": 200, "batch_pos": 200, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_17736", "batch_size": 200, "batch_pos": 192, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports factual information about funding use without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_1320", "batch_size": 200, "batch_pos": 186, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_19388", "batch_size": 200, "batch_pos": 147, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment states funds will be used, but contains no bare negation or explicit calming cue.", "method": "llm_batch", "batch_id": "batch_7_14212", "batch_size": 200, "batch_pos": 139, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes how funds will be used ('will be used to complete late-stage development and testing') which is a capability/preparedness measure without explicit reassurance.", "method": "llm_batch", "batch_id": "batch_8_14732", "batch_size": 200, "batch_pos": 179, "statement_text": "Funds from the U.S. Biomedical Advanced Research and Development Authority will be used to complete late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.", "article_id": 1745}
